Journal article
Not all tumors are alike: varying efficacy of FLASH across tumor types and oxygenation status in spheroid models
- Abstract:
- Objectives: Ultra-high dose rate irradiation (UHDR) has been shown to spare normal tissue in various model systems. This study evaluates its potential to sterilize cancer cells using spheroid tumor models. Methods: Spheroids from glioblastoma (U87), hypopharyngeal squamous cell carcinoma (2 sizes, FaDusmall and FaDularge) and breast adenocarcinoma (T47D) cells were irradiated with electron beams using UHDR (>200 Gy/s) or conventional dose rate (CONV, ∼0.1 Gy/s) exposures under ambient or reduced oxygen (1%) conditions. U87 and FaDusmall were also irradiated with protons. Spheroids were monitored using imaging for up to 100 days to determine the dose required to cure 50% of spheroids (SCD50). These data were used to calculate dose-modifying factor estimates for UHDR at the 50% survival level (DMFSCD50). Results: A total of 3230 spheroids were analyzed. Under ambient oxygen tension, UHDR and CONV showed no significant differences in U87 (DMFSCD50 = 0.98, P = .47), FaDusmall (DMFSCD50 = 1.01, P = .75), and T47D (DMFSCD50 = 1.04, P = .25), regardless of electron or proton irradiation. Under reduced oxygen levels, significantly higher UHDR doses were required to sterilize the spheroids, with DMFSCD50 1.14 (U87, P < .01), 1.07 (FaDusmall, P = .02), and 1.13 (T47D, P < .01). FaDularge-spheroids irradiated under ambient oxygen showed a DMFSCD50 of 1.66 (P < .001). Conclusion: Using spheroid tumor models with long follow-up, we demonstrate that efficacy of UHDR varies across cancer types and conditions. Whereas small spheroids exhibit iso-efficacy, both reduced oxygen tension and increased spheroid size lead to higher DMF. Advances in knowledge: This preclinical study suggests that tumor iso-efficacy with UHDR may not hold true for all cancer types and is associated with oxygen level.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.5MB, Terms of use)
-
- Publisher copy:
- 10.1093/bjr/tqaf219
Authors
+ Mrs. Berta Kamprad's Cancer Foundation
More from this funder
- Funder identifier:
- https://ror.org/04wv8j283
+ Gunnar Nilsson Cancer Foundation
More from this funder
- Funder identifier:
- https://ror.org/00292rj97
+ Swedish Society for Medical Research
More from this funder
- Funder identifier:
- https://ror.org/0433fd238
- Publisher:
- British Institute of Radiology
- Journal:
- British Journal of Radiology More from this journal
- Volume:
- 99
- Issue:
- 1177
- Pages:
- 65-72
- Publication date:
- 2025-08-28
- Acceptance date:
- 2025-08-20
- DOI:
- EISSN:
-
1748-880X
- ISSN:
-
0007-1285
- Language:
-
English
- Keywords:
- Pubs id:
-
2287819
- UUID:
-
uuid_94a5a1eb-a6c4-4a54-9b1f-9048582ef462
- Local pid:
-
pubs:2287819
- Source identifiers:
-
3740588
- Deposit date:
-
2026-02-09
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2025
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record